Overview

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Status:
Terminated

Trial end date:
2019-02-01

Target enrollment:

Participant gender:

Summary

Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.

Phase:

Phase 1

Details

Lead Sponsor:

Wills Eye

Collaborator:

University of Medicine and Dentistry of New Jersey

Treatments:

Lubricant Eye Drops
Timolol